Hsph1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
HSPH1 (Heat Shock Protein Family H (Hsp110) Member 1), also known as Hsp105 or Hsp110, is a member of the Hsp110 family of heat shock proteins. It plays important roles in protein quality control and is encoded by the HSPH1 gene located on chromosome 14q21.3.
| Attribute | Value |
|---|---|
| Gene Symbol | HSPH1 |
| Full Name | Heat Shock Protein Family H (Hsp110) Member 1 |
| Chromosomal Location | 14q21.3 |
| NCBI Gene ID | 10884 |
| Ensembl ID | ENSG00000120655 |
| UniProt ID | Q9Y617 |
| OMIM | 607547 |
HSPH1 encodes a protein of approximately 110 kDa. It contains:
HSPH1/Hsp105 functions as a:
HSPH1 is expressed in:
The study of Hsph1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
HSPH1 encodes Hsp105/Hsp110, a member of the Hsp110 subfamily of Hsp70-related proteins. Unlike canonical Hsp70s, Hsp110 functions primarily as a co-chaperone that enhances the activity of Hsp70 and Hsc70 in protein folding, refolding, and degradation. The protein contains an N-terminal ATPase domain that regulates substrate binding, a middle domain that interacts with Hsp70 family members, and a C-terminal substrate-binding domain with an EEVD motif for co-chaperone interactions.
One of the key functions of Hsp105 is its role in the Hsp70/Hsp110 disaggregase system. When proteins aggregate due to stress or misfolding, Hsp105 can work in conjunction with Hsp70 and Hsp40 family members to disassemble these aggregates and refold the constituent proteins. This activity is particularly important in neurons, which are highly vulnerable to protein aggregate toxicity due to their post-mitotic nature and long lifespan.
Hsp105 also plays a crucial role in antigen processing for MHC class I presentation. The protein binds to denatured or misfolded proteins in the cytosol and targets them for proteasomal degradation, generating peptides for presentation to CD8+ T cells. This function has implications for immune surveillance of tumor cells and viral infections.
Hsp105 represents a potential therapeutic target for neurodegenerative diseases:
Preclinical studies have shown that Hsp105 overexpression can protect against neurodegeneration in cellular and animal models of AD, ALS, and polyglutamine diseases. The therapeutic potential is particularly promising for diseases characterized by protein aggregation, including Huntington's disease, spinocerebellar ataxias, and frontotemporal dementia.
Current research areas include:
HSPH1 knockout mice are viable but show increased sensitivity to stress:
These models underscore the importance of Hsp105 in cellular stress responses and disease pathogenesis.